Parliamentary panel for framing price control regime for COVID medicines, medical devices, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Citing the example of non-scheduled drug Remdesivir the price for which varied up to Rs 5,400 per vial but reduced to less than Rs 3,500 per vial voluntarily by major manufacturers and marketers after “proactive” government intervention, the panel suggested effective price control of non-scheduled COVID-19 related medicines and medical devices., Citing the example of non-scheduled drug Remdesivir the price for which varied up to Rs 5,400 per vial but reduced to less than Rs 3,500 per vial voluntarily by major manufacturers and marketers after “proactive” government intervention, the panel suggested effective price control of non-scheduled COVID-19 related medicines and medical devices., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *